Arbutus Biopharma Balance Sheet (2010-2026)

Reported Financials

Arbutus Biopharma Quarterly Balance Sheet

Periods 57 quarters

Latest Jun 2026

Arbutus Biopharma reported total assets of $274.02M and total liabilities of $15.29M for the quarter ended Jun 2026, up 165.4% year over year. This balance sheet covers 57 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	77.88M	109.28M	81.33M	47.32M	24.00M	30.78M	40.57M	27.20M	17.53M	26.29M	43.10M	62.79M	31.85M	36.33M	37.08M	37.41M	22.41M	18.01M	23.71M	19.17M
Short-term InvestmentsInvestments (Current)	43.52M	46.03M	84.15M	102.88M	110.71M	116.14M	106.15M	125.29M	116.65M	99.72M	86.14M	79.20M	95.95M	86.29M	75.63M	60.68M	71.29M	73.46M	71.52M	73.45M
Cash & Current Investments	121.40M	155.32M	165.48M	150.20M	134.72M	146.91M	146.73M	152.48M	134.18M	126.00M	129.24M	141.99M	127.79M	122.62M	112.71M	98.09M	93.70M	91.47M	95.23M	92.62M
Receivables - NetNet Receivables	1.67M	0.90M	1.31M	1.97M	1.83M	1.35M	2.66M	2.61M	2.17M	1.78M	2.14M	1.77M	1.61M	2.41M	1.18M	1.02M	0.91M	1.45M	178.74M	179.37M
Receivables - OtherOther Receivables
Receivables	1.67M	0.90M	1.31M	1.97M	1.83M	1.35M	2.66M	2.61M	2.17M	1.78M	2.14M	1.77M	1.61M	2.41M	1.18M	1.02M	0.91M	1.45M	178.74M	179.37M
Finished Goods
Prepaid Assets	3.47M	4.45M	5.91M	5.62M	4.58M	2.87M	3.46M	3.70M	5.26M	4.25M	4.49M	4.47M	3.38M	2.28M	2.92M	4.01M	2.83M	1.54M	1.73M	1.52M
Current Assets	126.54M	160.66M	172.70M	157.79M	141.14M	151.14M	152.85M	158.80M	141.61M	132.03M	135.87M	148.22M	132.78M	127.32M	116.81M	103.12M	97.44M	94.46M	277.01M	273.88M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	6.35M	5.98M	5.66M	5.49M	5.24M	5.07M	4.85M	5.37M	5.03M	4.67M	4.41M	4.06M	3.56M	3.31M	0.17M	0.15M	0.14M	0.03M	0.02M	0.01M
Long-Term Investments	30.53M	35.69M	56.32M	50.45M	55.44M	37.36M	31.79M	11.06M	10.50M	6.28M	8.68M	6.53M	2.96M
Goodwill
Intangibles
Goodwill & Intangibles
Other Non-Current Assets		0.06M	0.19M	0.18M	0.17M	0.10M	0.06M	0.01M	0.00M					0.03M	0.03M		0.13M	0.13M	0.13M	0.13M
Non-Current Assets	39.06M	43.82M	64.18M	58.05M	62.66M	44.28M	38.37M	18.02M	17.03M	12.37M	14.42M	11.82M	7.66M	4.39M	0.20M	0.15M	0.27M	0.16M	0.15M	0.14M
Assets	165.60M	204.49M	236.88M	215.84M	203.80M	195.42M	191.22M	176.82M	158.64M	144.40M	150.29M	160.04M	140.44M	131.71M	117.01M	103.27M	97.71M	94.62M	277.16M	274.02M
Liabilities
Current Liabilities
Accounts Payables	9.73M	10.84M	8.71M	12.47M	12.27M	16.03M	9.65M	8.80M	9.81M	10.27M	8.25M	11.11M	7.54M	7.56M	12.11M	4.51M	4.65M	5.46M	4.47M	2.85M
Payables	9.73M	10.84M	8.71M	12.47M	12.27M	16.03M	9.65M	8.80M	9.81M	10.27M	8.25M	11.11M	7.54M	7.56M	12.11M	4.51M	4.65M	5.46M	4.47M	2.85M
Accumulated Expenses
Other Accumulated Expenses
Current Deferred Revenue			23.25M	16.97M	14.88M	16.46M	15.05M	15.33M	12.11M	11.79M	11.55M	11.03M	10.91M	7.57M	6.76M
Total Current Liabilities	10.11M	11.22M	32.41M	29.82M	27.51M	32.86M	25.15M	24.53M	22.32M	22.49M	20.30M	22.59M	18.92M	15.62M	19.43M	5.02M	5.18M	6.01M	5.11M	3.36M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue			15.59M	10.84M	10.59M	6.00M	3.30M							2.86M	2.86M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases	2.35M	2.23M	2.10M	2.09M	1.96M	1.81M	1.67M	1.65M	1.50M	1.34M	1.18M	1.14M	0.98M	0.81M	0.63M	0.57M	0.39M	0.20M
Other Non-Current Liabilities	17.88M	16.30M	15.44M	14.23M	12.32M	10.37M	9.38M	8.79M	8.11M	7.60M	7.78M	7.99M	8.34M	10.22M	10.52M	10.78M	11.10M	8.39M	8.60M	8.82M
Total Non-Current Liabilities	17.57M	18.75M	55.59M	48.46M	45.97M	48.20M	37.92M	33.34M	31.19M	30.78M	27.87M	29.60M	25.22M	24.12M	27.33M	9.51M	9.21M	9.65M	8.38M	6.47M
Total Liabilities	35.46M	35.05M	71.03M	62.69M	58.28M	58.57M	47.31M	42.13M	39.30M	38.38M	35.65M	37.59M	33.55M	34.34M	37.85M	20.29M	20.31M	18.04M	16.99M	15.29M
Shareholder's Equity
Total Debt
Common Equity	130.14M	169.44M	165.84M	153.14M	145.52M	136.85M	143.91M	134.69M	119.34M	106.02M	114.64M	122.45M	106.89M	97.37M	79.16M	82.98M	77.40M	76.58M	260.18M	258.73M
Liabilities and Shareholders Equity	165.60M	204.49M	236.88M	215.84M	203.80M	195.42M	191.22M	176.82M	158.64M	144.40M	150.29M	160.04M	140.44M	131.71M	117.01M	103.27M	97.71M	94.62M	277.16M	274.02M
Retained Earnings	-1112.45M	-1134.35M	-1150.11M	-1164.30M	-1181.87M	-1203.80M	-1220.14M	-1237.24M	-1257.34M	-1276.65M	-1294.53M	-1314.32M	-1334.04M	-1346.57M	-1371.10M	-1368.58M	-1376.32M	-1380.07M	-1210.38M	-1215.52M
Preferred Shares	160.97M

Arbutus Biopharma Balance Sheet API

Pull Arbutus Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABUS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "ABUS", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=ABUS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Arbutus Biopharma ABUS Balance Sheet (2010-2026)

Arbutus Biopharma Quarterly Balance Sheet

Arbutus Biopharma Balance Sheet API

Create an account

Sign In

Reset Password